GENEVA, Dec. 2 -- SONOMA BIOTHERAPEUTICS, INC. (201 Haskins Way, Suite 203South San Francisco, California 94080) filed a patent application (PCT/US2025/030455) for "MYELIN OLIGODENDROCYTE GLYCOPROTEIN-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE" on May 21, 2025. With publication no. WO/2025/245287, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHASE, John (c/o Sonoma Biotherapeutics, Inc.201 Haskins Way, Suite 203South San Francisco, California 94080), JOHNSON, Rebecca (c/o Sonoma Biotherapeutics, Inc.201 Has...